Skip to main content
OpenTrials

Clinical trial condition

Neovascular Age-related Macular Degeneration

Explore clinical trials studying Neovascular Age-related Macular Degeneration. Study availability and eligibility vary by location and protocol.

148 public trials 13 recruiting studies
Refine in advanced search Browse all conditions

Neovascular Age-related Macular Degeneration trial results

Completed

Safety and Efficacy of AM712 in Patients with NAMD

NCT05345769

Conditions
Neovascular Age-related Macular Degeneration
Locations
  • Retina Consultants San Diego Poway, California, United States
  • Bay Area Retina Associates Walnut Creek, California, United States
  • Colorado Retina Lakewood, Colorado, United States
  • Florida Eye Associates Melbourne, Florida, United States
View Trial Details
Completed

Study of Efficacy and Safety of Brolucizumab vs. Aflibercept in Chinese Patients With Neovascular Age-Related Macular Degeneration

NCT04047472

Conditions
Eye Diseases, Macular Degeneration, Neovascular Age-related Macular Degeneration, +9 more
Locations
  • Novartis Investigative Site Beijing, Beijing Municipality, China
  • Novartis Investigative Site Guangzhou, Guangdong, China
  • Novartis Investigative Site Guangzhou, Guangdong, China
  • Novartis Investigative Site Shantou, Guangdong, China
View all 30 locations
View Trial Details
Completed

Study of Brolucizumab in Adult Patients With Suboptimal Anatomically Controlled Neovascular Age-related Macular Degeneration

NCT04264819

Conditions
Cardiovascular Diseases, Choroid Diseases, Choroidal Neovascularization, +22 more
Locations
  • Novartis Investigative Site Nice, Cedex1, France
  • Novartis Investigative Site Rennes, FRA, France
  • Novartis Investigative Site Saint-Cyr-sur-Loire, Indre Et Loire, France
  • Novartis Investigative Site Lyon, Rhone, France
View all 51 locations
View Trial Details
Completed

An Extension Study Assessing the Efficacy and Safety of Brolucizumab in a Treat-to-Control Regimen in Patients With Neovascular Age-related Macular Degeneration Who Have Completed the CRTH258A2303 (TALON) Study

NCT04597632

Conditions
Choroid Diseases, Choroidal Neovascularization, Eye Diseases, +16 more
Locations
  • Novartis Investigative Site Huntington Beach, California, United States
  • Novartis Investigative Site Fort Lauderdale, Florida, United States
  • Novartis Investigative Site Indianapolis, Indiana, United States
  • Novartis Investigative Site Minneapolis, Minnesota, United States
View all 60 locations
View Trial Details
Completed

RGX-314 Gene Therapy Pharmacodynamic Study for Neovascular Age-related Macular Degeneration (nAMD)

NCT04832724

Conditions
Eye Diseases, Macular Degeneration, Neovascular Age-related Macular Degeneration, +4 more
Locations
  • Retinal Consultants of Arizona Phoenix, Arizona, United States
  • Barnet Dulaney Perkins Eye Center Sun City, Arizona, United States
  • Retina Consultants of San Diego San Diego, California, United States
  • California Retina Consultants Santa Barbara, California, United States
View all 13 locations
View Trial Details
Completed

Safety, Tolerability, and Efficacy Study of UBX1325 in Patients With Neovascular Age-Related Macular Degeneration (ENVISION)

NCT05275205

Conditions
Neovascular Age-related Macular Degeneration
Locations
  • Retina-Vitreous Associates Medical Group Beverly Hills, California, United States
  • Salehi Retina Institute Huntington Beach, California, United States
  • Advanced Vision Research Institute Longmont, Colorado, United States
  • Rand Eye Institute Deerfield Beach, Florida, United States
View all 14 locations
View Trial Details

Related conditions